|Title||New Peak Detection Performance Metrics from the MAM Consortium Interlaboratory Study.|
|Publication Type||Journal Article|
|Year of Publication||2021|
|Authors||Mouchahoir, T, Schiel, JE, Rogers, R, Heckert, A, Place, BJ, Ammerman, A, Li, X, Robinson, T, Schmidt, B, Chumsae, CM, Li, X, Manuilov, AV, Yan, B, Staples, GO, Ren, D, Veach, AJ, Wang, D, Yared, W, Sosic, Z, Wang, Y, Zang, L, Leone, AM, Liu, P, Ludwig, R, Tao, L, Wu, W, Cansizoglu, A, Hanneman, A, Adams, GW, Perdivara, I, Walker, H, Wilson, M, Brandenburg, A, DeGraan-Weber, N, Gotta, S, Shambaugh, J, Alvarez, M, X Yu, C, Cao, L, Shao, C, Mahan, A, Nanda, H, Nields, K, Nightlinger, N, Barysz, HMaria, Jahn, M, Niu, B, Wang, J, Leo, G, Sepe, N, Liu, Y-H, Patel, BA, Richardson, D, Wang, Y, Tizabi, D, Borisov, OV, Lu, Y, Maynard, EL, Gruhler, A, Haselmann, KF, Krogh, TN, Sönksen, CP, Letarte, S, Shen, S, Boggio, K, Johnson, K, Ni, W, Patel, H, Ripley, D, Rouse, JC, Zhang, Y, Daniels, C, Dawdy, A, Friese, O, Powers, TW, Sperry, JB, Woods, J, Carlson, E, K Sen, I, Skilton, SJohn, Busch, M, Lund, A, Stapels, M, Guo, X, Heidelberger, S, Kaluarachchi, H, McCarthy, S, Kim, J, Zhen, J, Zhou, Y, Rogstad, S, Wang, X, Fang, J, Chen, W, Yu, YQing, Hoogerheide, JG, Scott, R, Yuan, H|
|Journal||J Am Soc Mass Spectrom|
|Date Published||2021 Mar 12|
The Multi-Attribute Method (MAM) Consortium was initially formed as a venue to harmonize best practices, share experiences, and generate innovative methodologies to facilitate widespread integration of the MAM platform, which is an emerging ultra-high-performance liquid chromatography-mass spectrometry application. Successful implementation of MAM as a purity-indicating assay requires new peak detection (NPD) of potential process- and/or product-related impurities. The NPD interlaboratory study described herein was carried out by the MAM Consortium to report on the industry-wide performance of NPD using predigested samples of the NISTmAb Reference Material 8671. Results from 28 participating laboratories show that the NPD parameters being utilized across the industry are representative of high-resolution MS performance capabilities. Certain elements of NPD, including common sources of variability in the number of new peaks detected, that are critical to the performance of the purity function of MAM were identified in this study and are reported here as a means to further refine the methodology and accelerate adoption into manufacturer-specific protein therapeutic product life cycles.
|Alternate Journal||J Am Soc Mass Spectrom|